World's largest scientific symposium for interventional vascular therapy

This week marked the 15th annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium sponsored by the  Cardiovascular Research Foundation (CRF) and the Lenox Hill Heart and Vascular Institute of New York.

The symposium drew more than 10,000 academic, clinical and healthcare leaders to Washington, D.C., from more than 80 countries worldwide. The five-day event was dedicated to interventional vascular therapy and vascular medicine.

In addition to a list of presentations highlighting research conducted on the specialty, several manufacturers showcased new technologies in the field of interventional cardiology.

Philips Medical Systems  displayed its new enhanced cardiac catheterization lab, the Integris Allura Flat Detector, and Fresco, an interventional tool designed to enhance stent visualization.

 Toshiba American Medical Systems demonstrated its Infinix DP-I imaging system. Its dual-plane design allows one C-arm with a 9-inch image intensifier to be dedicated to cardiac and a second C-arm with a 16-inch image intensifier to handle peripheral procedures.

 Siemens Medical Solutions USA  featured a wide range of cardiology products, including the Axiom Artis dFC magnetic navigation system, Sorian cardiology and the Acuson AcuNav diagnostic ultrasound catheter.

GE Medical Systems Information Technologies (GEMSIT) exhibited an integrated system -- currently awaiting FDA 510(k) approval - designed to allow clinicians to access a cardiac patient's complete medical history, electronic images and other important information at one location. The technology, called MacLab IT and CardioLab IT, links GEMSIT's MacLab (hemodynamics), and CardioLab (electrophysiology) systems with the Centricity cardiology information system.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.